Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Bellon Christine. Officer active across 1 company, notably Beam Therapeutics Inc.. Cumulatively, 20 disclosures have been published. Breakdown: 0 buy · 14 sells. Total volume traded: €1.1m. Activity tracked since 30 March 2023. The latest transaction was disclosed on 1 April 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Bellon Christine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
5,956 shares@ US$24.5811.2% of flowCommon StockSEC:0001193125-26-144067:0
20,000 shares0Common StockSEC:0001193125-26-140586:0
1,371 shares@ US$34.003.3% of flowCommon StockSEC:0001193125-26-022557:0
2,111 shares@ US$33.62196.1% of flowCommon StockSEC:0001193125-26-016552:0
15,959 shares@ US$34.718247.4% of flowCommon StockSEC:0001193125-26-016552:1
559 shares@ US$35.39881.7% of flowCommon StockSEC:0001193125-26-016552:2
1,254 shares@ US$27.102.4% of flowCommon StockSEC:0001193125-26-002427:0
373 shares@ US$24.530.7% of flowCommon StockSEC:0001193125-25-230148:0
5,674 shares@ US$18.35079.6% of flowCommon StockSEC:0000950170-25-050859:0
20,000 shares0Common StockSEC:0000950170-25-049769:0
9,492 shares@ US$7.226.5% of flowCommon StockSEC:0000950170-25-023166:0
1,241 shares@ US$24.682.9% of flowCommon StockSEC:0000950170-25-002358:0
385 shares@ US$23.47940.8% of flowCommon StockSEC:0000950170-24-111739:0
3,401 shares@ US$32.1210.1% of flowCommon StockSEC:0000950170-24-041438:0
27,500 shares0Common StockSEC:0000950170-24-040150:0
1,907 shares@ US$26.424.6% of flowCommon StockSEC:0000950170-24-002480:0
4,182 shares@ US$7.222.8% of flowCommon StockSEC:0000950170-23-065868:0
388 shares@ US$22.850.8% of flowCommon StockSEC:0000950170-23-051915:0
931 shares@ US$30.312.6% of flowCommon StockSEC:0000899243-23-010817:0
6,272 shares@ US$7.224.1% of flowCommon StockSEC:0000899243-23-010140:0
About Bellon Christine
Bellon Christine is a declarant linked to Beam Therapeutics Inc. (XNAS), where the listed role is Chief Legal Officer. The record shows 20 filings in total, and across the 20 sampled filings between 2023-03-31 and 2026-04-06, the figures indicate 0 in purchases and 1072953 in sales, with Cession as the dominant transaction nature.